Trial Profile
A phase 2 study of Depigoid Birch pollen extract for patients with rhinoconjuctivitis during the European 2006 birch pollen season.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Oct 2012
Price :
$35
*
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary)
- Indications Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.